Abstract
The isolated perfused cat hearts incorporated radioactive arachidonic (20:4) and stearic (18:0) acids in the rapidly metabolizing pool of membrane phospholipids. Stereospecific analysis of the phospholipid fractions studied revealed that all of the 20:4 was acylated at the sn-2 position and about 80% of 18:0 was acylated at the sn-1 position of the phospholipid fractions studied. Comparison of the radioactivities of 20:4 at 2-position to 18:0 at 1-position of individual phospholipid fractions obtained from ischemic and non-ischemic zones of the same heart after 40 min of LAD occlusion showed a significant decrease in the ratio (20:4/18:0) of radioactivities. This decrease (19–50%) in the ratio for phosphatidylcholine and phosphatidylethanolamine in the ischemic myocardium suggests that phospholipase A2 activity in comparison to A1 is accelerated due to ischemia. The decrease (16%) in the ratio for phosphatidylinositol (PI) probably suggests increased turnover due to stimulated PI-specific phospholipase C activity.
Isolated Purkinje fibers or moderator bands containing both Purkinje and muscle fibers were superfused with various concentrations of lysophosphoglycerides (lyso-PL) in tissue bath and electrophysiological characteristics (EP) were monitored. Concentrations of exogenously superfused lyso-PL equivalent to that of total lyso-PL found in ischemic porcine hearts (0.16 mM) or 3 times the amount did not alter EP of either fiber. When lyso-PL (0.4 mM) were produced endogenously in sarcolemma by superfusing with buffer containing phospholipase A2, no changes in EP were observed. When higher endogenous lyso-PL concentrations (0.6–1.0 mM) were produced, action potential deteriorated but normal EP recovered after 6 min of washing with oxygenated normal buffer. At complete recovery, lyso-PL levels in fibers remained high (0.4 mM). Superfusion of fibers with buffer containing phospholipase C which resulted in <1.0% loss of total phospholipids with no lyso-PL production, completely abolished AP in 6 min, the fibers remaining unresponsive to stimulus even after prolonged washings with oxygenated normal buffer. These results suggest that lyso-PL alone may not be responsible for the electrophysiological manifestations of ischemia and that the minor loss of sarcolemmal phospholipids play an important role in membrane dysfunction.
This work was supported by the Ontario Heart Foundation.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Kennett, F.F. and Weglicki, W.B. Circ. Res. 43:750–758, 1978.
Chien, K.R., Pfau, R.G., Farber, J.L. Am. J. Pathol. 97:505–529, 1979.
Katz, A.M. and Messineo, F.C. Circ. Res. 48:1–16, 1981.
Shaikh, N.A., Parson, I. and Downar, E. In: Myocardial Ischemia and Lipid Metabolism, (Eds. Ferrari, R., Katz, A., Shug, A. and Visioli, O.) Plenum Press, New York, 1984, pp. 63–80.
Chien, K.R., Reeves, J.P., Buja, L.M., Bonte, F., Parkey, R.W. and Willerson, J.T. Circ. Res. 48:711–719, 1981.
Shen, A.C. and Jennings, R.B. Am. J. Pathol. 67:417–440, 1972.
Taylor, I.M., Shaikh, N.A. and Downar, E. J. Mol. Cell. Cardiol. 16:7994, 1984.
Sobel, B.E., Corr, P.B., Robinson, A.K., Goldstein, R.A., Witkowski, F.X. and Klein, M.S. J. Clin. Invest. 62:546–553, 1978.
Shaikh, N.A. and Downar, E. Circ. Res. 49:316–325, 1981.
Katz, A.M. J. Mol. Cell. Cardiol. 14:627–732, 1982.
Vusse van der, G.J., Roemen, T.H.M., Prinzen, R.W., Coumans, W.A. and Reneman, R.S. Circ. Res. 50:538–546, 1982.
Sobel, B.E. and Corr, P.B. In: Advances in Cardiology, Vol. 26, (Ed. John H.K. Vogel), Karger, Basel, Switzerland, 1979, pp. 76–85.
Corr, P.B., Cain, M.E., Witkowski, F.X., Price, D.A. and Sobel, B.E. Circ. Res. 44:822–832, 1979.
Corr, P.B., Bnyder, D.W., Cain, M.E., Crafford, W.A. Jr., Gross, R.W. and Sobel, B.E. Circ. Res. 49:354–363, 1981.
Man, R.Y.K. and Choy, P.C. J. Mol. Cell. Cardiol. 14:173–175, 1982.
Vasdev, S.C., Biro, G.P., Narbaitz, R., Kako, K.J. Can. J. Biochem. 58:1112–1119, 1980.
Hsueh, W., Isakson, P.C. and Needleman, P. Prostaglandins 13:1073–1091, 1977.
Isakson, P.C., Raz, A., Hsueh, W. and Needleman, P. Adv. Prostaglandin Thromboxane Res. 3:113–120, 1978.
Downar, E., Janse, M.J., Durrer, D. Circulation 55:455–462, 1977.
Folch, J., Lees, M., Sloane-Stanely, G.H. J. Biol. Chem. 226:497–509, 1957.
Bartlett, G.R. J. Biol. Chem. 234:466–468, 1959.
Shaikh, N.A. and Palmer, F.B. J. Neurochem. 26:597–603, 1976.
Paltauf, F. FEBS Lett. 17:118–120, 1971.
Shaikh, N.A. and Palmer, F.B. J. Neurochem. 28:395–402, 1977.
Shaikh, N.A. and Kuksis, A. Can. J. Biochem. 61:370–377, 1983.
Kuksis, A., Myher, J.J., Geher, K., Shaikh, N.A., Brackenridge, W.C., Jones, G.J.L. and Little, J.A. J. Chromatogr. 182:1–26, 1980.
Chien, K.R., Sherman, C., Mittnacht, S. Jr., Farber, J.L. Arch. Biochem. Biophys. 205:614–622, 1980.
Shaikh, N.A. and Downar, E. J. Mol. Cell. Cardiol. 15(Suppl. I):171, 1983.
Neely, J.R. and Morgan, H.E. Ann. Rev. Physiol. 36:413–459, 1974.
Jesse, R.L. and Cohen, P. Biochem. J. 158:283–287, 1976.
Kennedy, E.P. Fed. Proc. 20:934–940, 1961.
Atherton, R.S. and Hawthorne, J.N. Eur. J. Biochem. 4:68–75, 1968.
Irvine, R.F., Hemington, N. and Dawson, R.M.C. Biochem. J. 122:605–607, 1978.
Irvine, R.F. and Dawson, R.M.C. J. Neurochem. 31:1427–1434, 1978.
White, D.A., Pounder, D.J. and Hawthorne, J.N. Biochim. Biophys. Acta. 242:99–107, 1971.
Shum, T.Y.P., Gray, N.C.C. and Strickland, K.P. Can. J. Biochem. 57:1359–1367, 1979.
Hostetler, K.Y. and Hall, L.B. Biochem. Biophys. Res. Commun. 96:388–393, 1980.
Matsuzawa, Y. and Hostetler, K.Y. J. Biol. Chem. 255:646–652, 1980.
Opie, L.H. Circ. Res. 38(Suppl.I):52–74, 1976.
Kloner, R.A. and Braunwald, E. Cardiovasc. Res. 14:371–395, 1980.
Piper, H.M., Schwartz, P., Spahr, R., Rutter, J.F. and Spieckermann, P.G. J. Mol. Cell. Cardiol. 16:385–388, 1984.
Chien, K.R. J. Mol. Cell. Cardiol. 15(Suppl. III):3, 1983.
Weglicki, W.B., Waite, B.M. and Stam, A.C. J. Mol. Cell. Cardiol. 4:195–201, 1972.
Mookerjea, S. and Yung, J.W.M. Can. J. Biochem. 52:1053–1066, 1974.
Shier, W.T. and Trotter, J.T. III. FEBS Lett. 62:165–168, 1976.
Karli, J.N., Karikas, G.A., Hatzipavlou, P.K., Levis, G.M. and Moulopoulos, S.N. Life Sci. 24:1869–1876, 1979.
Arnsdorf, M.F. and Sawicki, F.J. Circ. Res. 49:16–30, 1981.
Riemersma, R.A. and Michorowski, B. Cardiovasc. Res. 17:505–508, 1983.
Weltzein, H.U. Biochim. Biophys. Acta. 559:259–287, 1979.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Martinus Nijhoff Publishing, Boston
About this chapter
Cite this chapter
Shaikh, N.A., Downar, E. (1985). Activation of Phospholipases during Myocardial Ischemia and Their Probable Role in Arrhythmogenesis. In: Stone, H.L., Weglicki, W.B. (eds) Pathobiology of Cardiovascular Injury. Developments in Cardiovascular Medicine, vol 49. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2621-2_22
Download citation
DOI: https://doi.org/10.1007/978-1-4613-2621-2_22
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9639-3
Online ISBN: 978-1-4613-2621-2
eBook Packages: Springer Book Archive